Financial Management Network Inc. Boosts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Financial Management Network Inc. grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 10.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 550 shares of the biotechnology company’s stock after acquiring an additional 50 shares during the period. Financial Management Network Inc.’s holdings in Axon Enterprise were worth $331,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in AXON. New Wave Wealth Advisors LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $40,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $45,000. Prestige Wealth Management Group LLC grew its stake in shares of Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock worth $33,000 after buying an additional 44 shares during the last quarter. Stonebridge Financial Group LLC purchased a new stake in shares of Axon Enterprise in the 4th quarter worth approximately $53,000. Finally, GPS Wealth Strategies Group LLC grew its stake in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after buying an additional 40 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In other Axon Enterprise news, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the completion of the sale, the director now owns 2,392 shares in the company, valued at approximately $1,631,487.52. This represents a 34.52 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,711 shares of company stock valued at $5,631,561. 5.70% of the stock is owned by company insiders.

Axon Enterprise Price Performance

NASDAQ AXON opened at $710.01 on Wednesday. Axon Enterprise, Inc. has a 1-year low of $260.27 and a 1-year high of $715.99. The business’s fifty day moving average price is $625.48 and its 200-day moving average price is $514.81. The stock has a market capitalization of $54.14 billion, a price-to-earnings ratio of 183.47, a PEG ratio of 6.85 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on AXON shares. JMP Securities upped their price target on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday, February 4th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group upped their price objective on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. TD Cowen initiated coverage on Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Finally, Robert W. Baird upped their price objective on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $542.15.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.